Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3941107
Max Phase: Preclinical
Molecular Formula: C19H19FN4O3S
Molecular Weight: 402.45
Molecule Type: Small molecule
Associated Items:
ID: ALA3941107
Max Phase: Preclinical
Molecular Formula: C19H19FN4O3S
Molecular Weight: 402.45
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: O=C(Nc1nc2c(s1)COCC2)N1CCC(c2noc3ccc(F)cc23)CC1
Standard InChI: InChI=1S/C19H19FN4O3S/c20-12-1-2-15-13(9-12)17(23-27-15)11-3-6-24(7-4-11)19(25)22-18-21-14-5-8-26-10-16(14)28-18/h1-2,9,11H,3-8,10H2,(H,21,22,25)
Standard InChI Key: BUZUDCIRABIRLU-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 402.45 | Molecular Weight (Monoisotopic): 402.1162 | AlogP: 3.91 | #Rotatable Bonds: 2 |
Polar Surface Area: 80.49 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 7.77 | CX Basic pKa: | CX LogP: 2.67 | CX LogD: 2.53 |
Aromatic Rings: 3 | Heavy Atoms: 28 | QED Weighted: 0.70 | Np Likeness Score: -2.16 |
1. (2016) Substituted piperidinyl-carboxamide derivatives useful as SCD 1 inhibitors, |
Source(1):